3,5-Dihydroxy-4-methylbenzoic acid
CAS No. 28026-96-2
3,5-Dihydroxy-4-methylbenzoic acid( —— )
Catalog No. M32036 CAS No. 28026-96-2
3,5-Dihydroxy-4-methylbenzoic acid is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 31 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 65 | In Stock |
|
| 100MG | 93 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 222 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3,5-Dihydroxy-4-methylbenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description3,5-Dihydroxy-4-methylbenzoic acid is a natural product.
-
Description3,5-Dihydroxy-4-methylbenzoic acid is a natural product.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28026-96-2
-
Formula Weight168.1
-
Molecular FormulaC8H8O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Atrial natriuretic f...
Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1.
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
GA-017
GA-017 is a potent, selective inhibitor of LATS1 and LATS2 (large tumor suppressor kinase 1/2), exhibiting IC50 values of 4.10 and 3.92 nM, respectively.
Cart
sales@molnova.com